Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank36
Studio
Year-over-Year Change

Return on equity

Latest
-55.97%
Near historical average
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-54.57%
Historical baseline
PeriodValueYoY Change
2025-55.97%-6.8%
2024-52.39%+31.0%
2023-75.95%+4.1%
2022-79.24%-43.9%
2021-55.05%-39.2%
2020-39.54%+40.2%
2019-66.08%-149.3%
2018-26.51%+58.1%
2017-63.28%-99.7%
2016-31.69%-